Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study

BACKGROUND: We compared all-cause mortality, major macrovascular events (MACE) and diabetes-related hospitalizations in T2DM-incident patients newly treated with metformin (MET) versus sulphonylureas (SU) monotherapy and in T2DM-prevalent patients newly treated with MET+SU versus MET+DPP4-inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilke, Thomas, Mueller, Sabrina, Groth, Antje, Berg, Bjoern, Hammar, Niklas, Tsai, Katherine, Fuchs, Andreas, Stephens, Stephanie, Maywald, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969981/
https://www.ncbi.nlm.nih.gov/pubmed/27486568
http://dx.doi.org/10.1186/s40200-016-0251-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969981/
https://www.ncbi.nlm.nih.gov/pubmed/27486568
http://dx.doi.org/10.1186/s40200-016-0251-9

Ejemplares similares